Rejko Krüger, MD, University of Luxembourg, Belvaux, Luxembourg, discusses the role of the gut microbiome in the pathogenesis of Parkinson’s disease (PD), which is an emerging topic in the field. Gastrointestinal dysfunction in PD was mentioned in the first description of the disease by James Parkinson. More recently, studies have reported increasing evidence for the role of the microbiome in PD. These studies have demonstrated that PD patients have an altered microbiome composition. Therefore, it is hypothesized that a dysregulated microbiota could be a biomarker of the pathological process or even contribute to the disease’s pathogenesis. This interview took place during the AD/PD™ 2021 conference.

свернуть